FDA suspends (and promptly restarts) clinical trial for new cancer therapy
Image of a T cell, a critical part of the human immune system, taken with a high-resolution electron microscope. [‘Healthy Human T Cell’ from NIAID]Bringing a new medical therapy to market is rarely a straightforward task, as a biotech…